Yes, the FDA recently approved three updated COVID vaccines for the 2026-2027 season that will target the JN.1 lineage XFG subvariant of the virus (SARS-CoV-2), and they are available. At the end of August, the Food and Drug Administration (FDA) approved updated COVID vaccines for the 2026/2027 season. Let’s break it down: They are Moderna’s Read more…